OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
Susan Haigney is managing editor of BioPharm International, firstname.lastname@example.org.
AstraZeneca will utilize Absci’s AI antibody drug creation platform to create an AI-designed antibody.
Biologics have specific quality considerations that make fast tracking these drugs more difficult.
The 3M Harvest RC Chromatographic Clarifier, BT500 is the latest addition to the company’s chromatographic clarifier portfolio.
How can sustainability and zero-carbon initiatives be achieved?
Aitia will access Charles River’s Logica drug solution platform to develop therapeutic programs for neurodegenerative disease and oncology.
Recommended medicines include treatments for generalized myasthenia gravis, glioma, neovascular age-related macular degeneration, and more.
Electronic product information for selected human medicines that have been harmonized across the European Union have been published for the first time.
The document includes recommendations for the reporting and implementation of changes to container closure system components.
The EC is calling for interested parties for their safety and orphan drug committees.
According to USP, the products will advance quality and reduce risk in the development and manufacture of biologics and vaccines.